These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 38336529)

  • 1. CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
    Kinoshita H; Bollard CM; Toner K
    Semin Hematol; 2023 Nov; 60(5):329-337. PubMed ID: 38336529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO.
    Bailén R; Iacoboni G; Delgado J; López-Corral L; Hernani-Morales R; Ortiz-Maldonado V; Guerreiro M; Caballero AC; Guerra-Domínguez ML; Sánchez-Pina JM; Peña M; Torrent A; Pérez-Martínez A; Bastos-Oreiro M; Reguera-Ortega JL; Martín A; Hernandez-Boluda JC; Martínez-Cibrián N; Sanz J; Briones J; Henriquez HL; Calbacho M; Mussetti A; Sancho JM; Barba P; Kwon M;
    Transplant Cell Ther; 2024 Oct; 30(10):988.e1-988.e11. PubMed ID: 39069076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis.
    Gagelmann N; Bishop M; Ayuk F; Bethge W; Glass B; Sureda A; Pasquini MC; Kröger N
    Transplant Cell Ther; 2024 Jun; 30(6):584.e1-584.e13. PubMed ID: 38281590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer: A Nonrandomized Clinical Trial.
    Chen N; Pu C; Zhao L; Li W; Wang C; Zhu R; Liang T; Niu C; Huang X; Tang H; Wang Y; Yang H; Jia B; Jiang X; Han G; Wang W; Chen D; Wang Y; Rowinsky EK; Kennedy E; Lu VX; Cui G; Wu Z; Xiao L; Cui J
    JAMA Oncol; 2024 Nov; 10(11):1532-1536. PubMed ID: 39298141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.
    Nakamura N; Jo T; Arai Y; Kitawaki T; Nishikori M; Mizumoto C; Kanda J; Yamashita K; Nagao M; Takaori-Kondo A
    Clin Exp Med; 2024 May; 24(1):105. PubMed ID: 38771501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes with loncastuximab tesirine following CAR T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma.
    Epperla N; Lucero M; Bailey T; Mirams L; Cheung J; Amet M; Milligan G; Chen L
    Blood Cancer J; 2024 Nov; 14(1):210. PubMed ID: 39609431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOHO State of the Art Updates and Next Questions | Current Evidence and Future Directions for Bispecific Antibodies in Large B-Cell Lymphoma.
    Bennett R; Dickinson M
    Clin Lymphoma Myeloma Leuk; 2024 Dec; 24(12):809-820. PubMed ID: 38871556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequencing bispecific antibodies and CAR T cells for FL.
    Russler-Germain DA; Bartlett NL
    Hematology Am Soc Hematol Educ Program; 2024 Dec; 2024(1):310-317. PubMed ID: 39643999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study.
    Iyer SP; Sica RA; Ho PJ; Prica A; Zain J; Foss FM; Hu B; Beitinjaneh A; Weng WK; Kim YH; Khodadoust MS; Huen AO; Williams LM; Ma A; Huang E; Ganpule A; Nagar SD; Sripakdeevong P; Cullingford EL; Karnik S; Dequeant ML; Patel JN; He XS; Li Z; He QA; Mendonez JH; Keegan A; Horwitz SM
    Lancet Oncol; 2024 Nov; ():. PubMed ID: 39617017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare workers' informal uses of mobile phones and other mobile devices to support their work: a qualitative evidence synthesis.
    Glenton C; Paulsen E; Agarwal S; Gopinathan U; Johansen M; Kyaddondo D; Munabi-Babigumira S; Nabukenya J; Nakityo I; Namaganda R; Namitala J; Neumark T; Nsangi A; Pakenham-Walsh NM; Rashidian A; Royston G; Sewankambo N; Tamrat T; Lewin S
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015705. PubMed ID: 39189465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy.
    Hughes CFM; Shah GL; Paul BA
    Front Oncol; 2024; 14():1373548. PubMed ID: 38601770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin for endometrial hyperplasia.
    Shiwani H; Clement NS; Daniels JP; Atiomo W
    Cochrane Database Syst Rev; 2024 May; 5(5):CD012214. PubMed ID: 38695827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms.
    Kearl TJ; Furqan F; Shah NN
    Cancer Metastasis Rev; 2024 Dec; 44(1):12. PubMed ID: 39617795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant Advancements and Evolutions in Chimeric Antigen Receptor Design.
    Gaimari A; De Lucia A; Nicolini F; Mazzotti L; Maltoni R; Rughi G; Zurlo M; Marchesini M; Juan M; Parras D; Cerchione C; Martinelli G; Bravaccini S; Tettamanti S; Pasetto A; Pasini L; Magnoni C; Gazzola L; Borges de Souza P; Mazza M
    Int J Mol Sci; 2024 Nov; 25(22):. PubMed ID: 39596267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Blog-Based Study of Autistic Adults' Experiences of Aloneness and Connection and the Interplay with Well-Being: Corpus-Based and Thematic Analyses.
    Petty S; Allen S; Pickup H; Woodier B
    Autism Adulthood; 2023 Dec; 5(4):437-449. PubMed ID: 38116056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression.
    Danylesko I; Shem-Tov N; Yerushalmi R; Jacoby E; Toren A; Shouval R; Itzhaki O; Avigdor A; Shimoni A; Nagler A
    Curr Res Transl Med; 2024 Dec; 72(4):103471. PubMed ID: 39305562
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.